# HUIZ earnings call intelligence LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/HUIZ) · [Earnings tab](https://www.lopjlb.com/stock/HUIZ?tab=earnings) Updated: 2026-08-22T06:29:02 Quarters analyzed: 8 ## Cross-quarter narrative Across 8 calls for HUIZ, management tone moved from +0.80 (2024 Q1) to +0.60 (2026 Q2). Latest guidance stance: maintained. Latest desk line: Huize posted record GWP of RMB 4.2 bn, 30% YoY growth, improved margins and profitability, while expanding AI tools and international operations, but notes macro uncertainty and regulatory headwinds. ## Latest CallCard · Q2 Huize posted record GWP of RMB 4.2 bn, 30% YoY growth, improved margins and profitability, while expanding AI tools and international operations, but notes macro uncertainty and regulatory headwinds. **Guidance:** maintained — Management reiterated priorities and expectations without raising or lowering explicit guidance. **Tone:** mgmt 0.6 · Q&A pressure 0.3 · divergence 0.3 Prepared remarks highlighted strong premium growth, improved operating efficiency and higher profitability, portraying an upbeat outlook. ### Demand visibility Strong demand for long‑term savings and health protection driven by low rates and demographics Low interest‑rate environment and shifting demographics are sustaining demand for retirement, wealth‑accumulation and health insurance products, with AI deepening customer engagement. ### Margins / costs Operating margin improving, expense ratio down to 24.2% Operating expenses fell to RMB 175 million, improving the expense‑to‑income ratio to 24.2%, though ongoing AI investment of ~USD 10 m pressures net profit margin. ### Capital allocation Capital focused on AI and scaling existing international operations Around USD 10 m invested in AI this year, cash balance RMB 241 million, no fundraising planned unless a major M&A opportunity arises; no new market entry in next 12‑24 months. ### Milestones - **AI app 2.0 multi‑agent architecture** [delivered]: Upgrade completed, user conversations up 65% year‑to‑date. - **AI financial planning feature** [new]: Launched to generate personalized family insurance plans. - **Xiao Ma Claim AI** [on_track]: End‑to‑end claim processing now completed within 1 hour for core products. - **Bliss 5.0 participating annuity** [new]: New annuity product launched to support wealth accumulation and retirement planning. - **Darwin No.15 Kids Protection** [new]: Integrates critical illness and long‑term medical coverage for children. - **Changxiang An 5.0 medical coverage** [new]: Expands mid‑to‑high‑end coverage for pre‑existing conditions. - **Poni Insurtech international revenue** [on_track]: Generated RMB 220 million in H1, with strong growth in Vietnam and Singapore. - **Vietnam GlobalCare expansion** [on_track]: Policies up 11% YoY, revenue up 24% YoY. ### Fears / risks - **Macro/geopolitical uncertainty**: Continued macro and geopolitical uncertainty could affect demand and operating environment. - **Regulatory risk (Decree 837)**: Potential impact of new tax decree on offshore insurance demand in Hong Kong. - **International profitability**: Vietnam not yet EBITDA positive and Singapore still ramping, profitability not guaranteed. - **AI investment cost**: Ongoing AI spend (~USD 10 m) pressures net profit margin. - **Customer acquisition reliance on AI**: Effectiveness of AI‑driven self‑service to lower CAC remains uncertain. - **Competitive pressure**: Need to maintain product innovation as market evolves. - **Interest‑rate environment**: Low rates drive demand but a shift could affect product attractiveness. - **Cash runway**: While cash is adequate, future large M&A could require additional funding. ### Key quotes > “We are unlikely to be raising capital at this stage because we still have decent cash on balance sheet.” — Kwok Ho Tam ## Quarter one-liners - **2026 Q2:** Huize posted record GWP of RMB 4.2 bn, 30% YoY growth, improved margins and profitability, while expanding AI tools and international operations, but notes macro uncertainty and regulatory headwinds. - **2025 Q4:** — - **2025 Q2:** — - **2025 Q1:** — - **2024 Q4:** Huize posted 4.5% revenue growth, record premiums and a 34.7% gross margin, while highlighting AI‑driven efficiency gains and international expansion, and guided to a profitable 2025 with mid‑single‑digit net margin. - **2024 Q3:** Huize posts record Q3 GWP of RMB 2.06B and net profit of RMB 18.7M; international revenue hits 19% driven by Hong Kong and Vietnam expansion; Q4 expected weaker due to front-loaded savings demand and product transition; gross margin compressed to ~27% from broker channel rationalization. - **2024 Q2:** Huize Q2 2024: GWP flat YoY at RMB1.34B, revenue RMB218M; long-term insurance 91.3% of GWP, renewals up 42.8%; international revenue 11% (target 30% by 2026), acquired Vietnam's Global Care, expanding in Southeast Asia; participating products expected to become mainstream. - **2024 Q1:** Huize posted 38% sequential GWP growth and sixth straight profitable quarter, highlighted AI tool rollouts and Hong Kong expansion, but flagged margin pressure from higher channel costs and regulatory changes. ## Theme arcs - **Management tone** (deteriorating): Δ mgmt=-0.20 ## Fear persistence - **regulatory reform** [resolved]: 2024 Q1 - **margin compression** [recurring]: 2024 Q1, 2024 Q4 - **health product demand** [resolved]: 2024 Q1 - **competitive pressure** [recurring]: 2024 Q1, 2026 Q2 - **expansion execution** [resolved]: 2024 Q1 - **commission decline** [resolved]: 2024 Q1 - **reliance on partners** [resolved]: 2024 Q1 - **technology adoption risk** [resolved]: 2024 Q1 - **regulatory and industry transformation** [resolved]: 2024 Q2 - **low interest rate environment** [resolved]: 2024 Q2 ## Guidance path 2024 Q1:maintained → 2024 Q2:vague → 2024 Q3:vague → 2024 Q4:maintained → 2025 Q1:vague → 2025 Q2:vague → 2025 Q4:vague → 2026 Q2:maintained --- Research context only. Not personalized investment advice. API: `GET /bff/api/bigfive/earnings-intel/HUIZ`